The combination of casirivimab and imdevimab is an investigational drug product being studied in the US and Canada to treat coronavirus disease, also known as COVID-19. In the US, this product is not FDA-approved; however, it is FDA-authorized for emergency use to treat COVID-19.
Casirivimab/imdevimab, sold under the brand name REGEN-COV among others, is a medicine developed by the American biotechnology company Regeneron Pharmaceuticals. It is an artificial "antibody cocktail" designed to produce resistance against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic
...more
ROCHE Casirivimab and Imdevimab
55,000 - 120,000 / vial
1 Box (MOQ)
The combination of casirivimab and imdevimab is an investigational drug product being studied in the US and Canada to treat coronavirus disease, also known as COVID-19. In the US, this product is not FDA-approved; however, it is FDA-authorized for emergency use to treat COVID-19.
Casirivimab/imdevimab, sold under the brand name REGEN-COV among others, is a medicine developed by the American biotechnology company Regeneron Pharmaceuticals. It is an artificial "antibody cocktail" designed to produce resistance against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic
Secondary Business TypeManufacturer / Wholesale Suppliers
Year of Establishment2017
No. of Employees21 - 50
Annual TurnoverBelow Rs. 0.5 Crore Approx.
Ownership TypeIndividual (Sole proprietorship)
GSTIN Number33AAGPC0908B1ZN
Opening Hours
SUN : Closed
MON : 9:30 AM - 6:30 PM
TUE : 9:30 AM - 6:30 PM
WED : 9:30 AM - 6:30 PM
THU : 9:30 AM - 6:30 PM
FRI : 9:30 AM - 6:30 PM
SAT : 9:30 AM - 6:30 PM
Medisat Pharmaceuticals is one of the established PCD companies in India, based out of Tamil Nadu and we sincerely aim to add value to human life. Medisat Pharmaceuticals provides business opportunities to the pharma professionals from all across the globe.
Reviews & Ratings
Write a Review
Post Free Ad
